Keywords: NCEP ATP 3; ASRM; American Society for Reproductive Medicine; BMI; body metabolic index; BP; blood pressure; CINAHL; cumulative index to nursing and allied health literature; DBP; diastolic blood pressure; EMBASE; excerpta medical database; ESHRE; European Society of
مقالات ISI NCEP ATP 3 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NCEP ATP 3; Metabolic syndrome; NCEP ATP III; Nutrients; Diets; Inflammation; Systematic review; Meta-analysis
Keywords: NCEP ATP 3; PAHs; Polycyclic aromatic hydrocarbons; CVD; Cardiovascular disease; T2DM; Type 2 diabetes mellitus; PM; Particulate matter; MetS; Metabolic syndrome; OH-PAHs; Monohydroxy urinary metabolites of PAHs; HOMA2; Updated Homeostasis Model Assessment; NHANES; N
Keywords: NCEP ATP 3; APL; Acquired partial lipodystrophy; CGL; Congenital generalized lipodystrophy; MPGN; Membranoproliferative glomerulonephritis; FPL; Familial partial lipodystrophy; TuLip; Turkish Lipodystrophy Study Group; WB MRI; Whole body magnetic resonance imaging; N
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Keywords: NCEP ATP 3; AHA; American Heart Association; AEPCOS; Androgen Excess PCOS Society; apoB; apolipoprotein B; apoA-I; apolipoprotein A-I; CAD; coronary artery disease; CHD; coronary heart disease; CI; confidence interval; CIMT; carotid artery intima-media thickness; CRP
Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients
Keywords: NCEP ATP 3; MACE; major adverse cardiovascular events; LDL-C; low-density lipoprotein cholesterol; ACS; acute coronary syndrome; PCI; percutaneous coronary intervention; CHD; coronary heart disease; CDARS; Clinical Data Analysis and Reporting System; ACA; American Co
Metabolic syndrome among diabetics and pre-diabetics of Jenu Kuruba tribe in Mysore district (JKDHS-2)-An evidence of metabolic abnormalities leading to increase in CVD's among Jenu Kuruba tribal population
Keywords: NCEP ATP 3; Metabolic syndrome; Diabetes; Jenu Kuruba tribe; Mysore; India; MS; metabolic syndrome; MI; myocardial infarction; WHO; World Health Organization; JKDHS; Jenu Kuruba Diabetes Hypertension Study; NCEP ATP III; National Cholesterol Education Programs Adult
Laboratory validation of a low density lipoprotein apolipoprotein-B assay
Keywords: NCEP ATP 3; Apo-B; apolipoprotein B; LDL; low density lipoprotein; LDL-C; low density lipoprotein cholesterol; LDL-P; low density lipoprotein particle number; VLDL; very low density lipoprotein; IDL; intermediate density lipoprotein; Lp(a); lipoprotein (a); CHD; coro
Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults
Keywords: NCEP ATP 3; ANOVA; analysis of variance; ANCOVA; analysis of co-variance; BMI; body mass index; CHD; coronary heart disease; CVD; cardiovascular disease; CHOD-PAP; cholesterol oxidase/p-aminophenazone; DHA; docosaheaxanoic acid; EPA; eicosapentaenoic acid; HDL-C; hig
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Keywords: NCEP ATP 3; prostatic neoplasms; gonadotropin-releasing hormone agonists; cardiovascular diseases; diabetes mellitus; obesity; ADA; American Diabetes Association; ADT; androgen deprivation therapy; AHR; adjusted hazard ratio; BMI; body mass index; CaPSURE; Cancer of
Promoting only the consumption of healthy foods may be an alternative stategy for treating patients with the metabolic syndrome
Keywords: NCEP ATP 3; NCEP ATP III; National Cholesterol Education Program Adult Treatment Panel III; ANOVA; Analysis of Variance;
Distribution of 10-year risk for coronary heart disease and eligibility for therapeutic approaches among Tehranian adults
Keywords: NCEP ATP 3; 10-Year risk; Coronary heart disease; Adults; NCEP ATP III
Prevalence of metabolic syndrome in patients with angiographically proven coronary artery disease presenting to a tertiary care hospital in Delhi, India
Keywords: NCEP ATP 3; Metabolic syndrome; NCEP ATP III; WHO; IDF; Coronary artery disease; Prevalence
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
Keywords: NCEP ATP 3; AFCAPS/TexCAPS; Air Force/Texas Coronary Atherosclerosis Prevention Study; AHA; American Heart Association; ASCOT-LLA; Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm; CAC; coronary artery calcium; CAD; coronary artery disease; CRP; C-reactiv
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study
Keywords: NCEP ATP 3; Metabolic syndrome; NCEP ATP III; Modified NCEP ATP III criteria; Schizophrenia; Outpatients; Antipsychotic treatment; Concordance
Cardiovascular Disease Risk Factors and the Relationships With Physical Activity, Aerobic Fitness, and Body Fat in Adolescents and Young Adults With Myelomeningocele
Keywords: NCEP ATP 3; Cardiovascular diseases; Physical fitness; Rehabilitation; Risk factors; Spina bifida cystica; CVD; cardiovascular disease; DBP; diastolic blood pressure; HDL-C; high-density lipoprotein cholesterol; JNC 7; Seventh Report of the Joint National Committee o
Abnormal Cardiac Structure and Function in the Metabolic Syndrome: A Population-Based Study
Keywords: NCEP ATP 3; CI; confidence interval; CVD; cardiovascular disease; LV; left ventricular; NCEP ATP III; National Cholesterol Education Program Adult Treatment Panel III; OCHFS; Olmsted County Heart Function Study;
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Keywords: NCEP ATP 3; prostatic neoplasms; gonadotropin-releasing hormone agonists; cardiovascular diseases; diabetes mellitus; obesity; ADA; American Diabetes Association; ADT; androgen deprivation therapy; AHR; adjusted hazard ratio; BMI; body mass index; CaPSURE; Cancer of
A Practical “ABCDE” Approach to the Metabolic Syndrome
Keywords: NCEP ATP 3; ACC; American College of Cardiology; ACEI; angiotensin-converting enzyme inhibitor; AHA; American Heart Association; ARB; angiotensin receptor blocker; CI; confidence interval; DREAM; Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medicatio
Toward “Pain-Free” Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia
Keywords: NCEP ATP 3; AE; adverse event; AERS; Adverse Event Reporting System; CI; confidence interval; CK; creatine kinase; CoQ10; coenzyme Q10; CYP; cytochrome P; FDA; Food and Drug Administration; HDL-C; high-density lipoprotein cholesterol; HMG-CoA; 3-hydroxy-3-methylgluta
The Metabolic Syndrome: Concepts and Controversy
Keywords: NCEP ATP 3; ACE; American College of Endocrinology/American Association of Clinical Endocrinologists; ADA; American Diabetes Association; BMI; body mass index; CVD; cardiovascular disease; DM; diabetes mellitus; EASD; European Association for the Study of Diabetes; F
The Safety of Aggressive Statin Therapy: How Much Can Low-Density Lipoprotein Cholesterol Be Lowered?
Keywords: NCEP ATP 3; CK; creatine kinase; CYP; cytochrome P-450; IDEAL; Incremental Decrease in End Points Through Aggressive Lipid Lowering; LDL-C; low-density lipoprotein cholesterol; NCEP ATP III; National Cholesterol Education Program Adult Treatment Panel III; PROVE IT-T
Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness T
Keywords: NCEP ATP 3; AE; adverse event; ALT; alanine aminotransferase; ANOVA; analysis of variance; AST; aspartate aminotransferase; CHD; coronary heart disease; CK; creatine kinase; CRP; C-reactive protein; CVD; cardiovascular disease; EASE; Ezetimibe Add-On to Statin for Ef
Ezetimibe/Simvastatin vs Atorvastatin in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia: The VYTAL Study
Keywords: NCEP ATP 3; ADA; American Diabetes Association; CAE; clinical adverse event; CHD; coronary heart disease; CI; confidence interval; CVD; cardiovascular disease; HDL-C; high-density lipoprotein cholesterol; hsCRP; high-sensitivity C-reactive protein; LAE; laboratory ad
A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial
Keywords: NCEP ATP 3; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CHD; coronary heart disease; CI; confidence interval; CK; creatine kinase; HDL-C; high-density lipoprotein cholesterol; hs-CRP; high-sensitivity C-reactive protein; LDL-C; low-density lipopro